115 related articles for article (PubMed ID: 8676012)
21. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
Lin JC; Park HJ; Song CW
Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
[TBL] [Abstract][Full Text] [Related]
22. Enhanced cytotoxicity and suppression of glucose transport rate by combined treatment of recombinant human tumour necrosis factor-alpha and hyperthermia on L929 cells.
Liong E; Kong SK; Au KK; Li JY; Xu GY; Lee YL; Kwok TT; Choy YM; Lee CY; Fung KP
Life Sci; 1999; 65(8):PL81-6. PubMed ID: 10466752
[TBL] [Abstract][Full Text] [Related]
23. A comparison between the effect of step-down heating in a tumour and a normal tissue in vivo.
Lindegaard JC; Nielsen OS; Overgaard J
Int J Hyperthermia; 1991; 7(3):519-26. PubMed ID: 1919147
[TBL] [Abstract][Full Text] [Related]
24. TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity.
Polla BS; Jacquier-Sarlin MR; Kantengwa S; Mariéthoz E; Hennet T; Russo-Marie F; Cossarizza A
Free Radic Res; 1996 Aug; 25(2):125-31. PubMed ID: 8885330
[TBL] [Abstract][Full Text] [Related]
25. Effects of step-up and step-down heating combined with radiation on murine tumor and normal tissues.
Hiraoka M; Miyakoshi J; Jo S; Takahashi M; Abe M
Jpn J Cancer Res; 1987 Jan; 78(1):63-7. PubMed ID: 3102440
[TBL] [Abstract][Full Text] [Related]
26. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
27. Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs.
Neale ML; Matthews N
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):133-7. PubMed ID: 2493381
[TBL] [Abstract][Full Text] [Related]
28. Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929 fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates.
Leroux E; Auzenne E; Weidner D; Wu ZY; Donato NJ; Klostergaard J
J Cell Physiol; 2001 May; 187(2):256-63. PubMed ID: 11268005
[TBL] [Abstract][Full Text] [Related]
29. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
Liddil JD; Dorr RT; Scuderi P
Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
[TBL] [Abstract][Full Text] [Related]
30. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
Beyaert R; Vanhaesebroeck B; Suffys P; Van Roy F; Fiers W
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9494-8. PubMed ID: 2556714
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic and necrotic effects of tumour necrosis factor-alpha potentiated with hyperthermia on L929 and tumour necrosis factor-alpha-resistant L929.
Lui PC; Fan YS; Xu G; Ngai CY; Fung KP; Tse GM; Yu AM; Li JY
Int J Hyperthermia; 2010; 26(6):556-64. PubMed ID: 20707650
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermic modulation of respiratory inhibition factor- and iron releasing factor-dependent macrophage murine tumor cytotoxicity.
Klostergaard J; Barta M; Tomasovic SP
Cancer Res; 1989 Nov; 49(22):6252-7. PubMed ID: 2680061
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis.
Niitsu Y; Watanabe N; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Feb; 48(3):654-7. PubMed ID: 2825981
[TBL] [Abstract][Full Text] [Related]
34. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts.
Mehlen P; Preville X; Chareyron P; Briolay J; Klemenz R; Arrigo AP
J Immunol; 1995 Jan; 154(1):363-74. PubMed ID: 7995955
[TBL] [Abstract][Full Text] [Related]
35. Tumor cure and cell survival after localized radiofrequency heating.
Marmor JB; Hahn N; Hahn GM
Cancer Res; 1977 Mar; 37(3):879-83. PubMed ID: 837383
[TBL] [Abstract][Full Text] [Related]
36. Basic principles in hyperthermic tumor therapy.
Dietzel F
Recent Results Cancer Res; 1983; 86():177-90. PubMed ID: 6647999
[TBL] [Abstract][Full Text] [Related]
37. Effect of step-down heating on hyperthermic radiosensitization in an experimental tumor and a normal tissue in vivo.
Lindegaard JC; Overgaard J
Radiother Oncol; 1988 Feb; 11(2):143-51. PubMed ID: 3353518
[TBL] [Abstract][Full Text] [Related]
38. Biological activity of mutants of human tumour necrosis factor-alpha.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Safrit JT; Berek JS; Bonavida B
Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
[TBL] [Abstract][Full Text] [Related]
40. Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo.
Lindegaard JC; Overgaard J
Int J Hyperthermia; 1987; 3(1):79-91. PubMed ID: 3559300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
